Skip to main content
logo
TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
52.03
-1.50 (-2.80%)
At close: Jul 31, 2026, 4:00 PM EDT
51.80
-0.23 (-0.44%)
After-hours: Jul 31, 2026, 7:59 PM EDT

TG Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
700.35616.29329233.662.796.69
Revenue Growth
81.26%87.32%40.80%8290.02%-58.36%4300.66%
Gross Profit
581.67515.57290.52219.532.525.9
Operating Income
149.5123.3241.9320.63-218.32-344.77
Net Income
461.9447.1823.3812.67-223.81-348.1
Earnings Per Share
2.862.770.150.09-1.65-2.63
EPS Growth
1091.67%1746.67%66.67%---

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Product Revenue, Net
688.58606.93313.7392.012.636.54
License
-0.150.15140.150.150.15
Milestone
--12.5---
Royalty
-5.620.8---
Other
-3.591.821.5--
Revenue (Total)
700.35616.29329233.662.796.69

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
514.43141.97311217.51161.68314.76
Total Debt
753.56253.71253.72110.883.0679.05
Net Cash (Debt)
-239.13-111.7457.28106.7178.62235.72
Net Cash Growth
---46.32%35.74%-66.65%-58.17%
Net Cash Per Share
-1.49-0.690.360.720.581.78

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-13.95-24.77-40.52-31.41-176.17-295.63
Capital Expenditures
-0.24-0.21-0.05--0.01-0.4
Free Cash Flow
-14.19-24.99-40.56-31.41-176.18-296.04
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
83.05%83.66%88.30%93.95%90.48%88.19%
Operating Margin
21.35%20.01%12.74%8.83%-7838.99%-5154.28%
Pretax Margin
17.46%17.43%7.78%5.59%-8036.34%-5204.08%
Profit Margin
65.95%72.56%7.11%5.42%-8036.34%-5204.08%
FCF Margin
-2.03%-4.05%-12.33%-13.44%-6326.18%-4425.70%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
18.1210.76200.67189.78--
Forward PE
31.1620.2945.21134.45--
PS Ratio
10.537.5114.2611.07621.81406.90